GAL and cancer: Gal-Alb uptake did not show concurrent results with the asialoglycoprotein receptor 1 (Asgr1) and galectin 9 (Lgals9) genes, implying that their uptake may be receptor-mediated by Slc2a1 and galectin 3 (Lgals3), or active-metabolism-driven by cancer cells.